Home Other Building Blocks Glyoxalbis(2-hydroxyanil)

Glyoxalbis(2-hydroxyanil)

CAS No.:
1149-16-2
Catalog Number:
AG000FFG
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.2573
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
>98.0%(N)
1 week
United States
$120
- +
25g
>98.0%(N)
1 week
United States
$249
- +
Product Description
Catalog Number:
AG000FFG
Chemical Name:
Glyoxalbis(2-hydroxyanil)
CAS Number:
1149-16-2
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.2573
MDL Number:
MFCD00002183
IUPAC Name:
2-[2-(2-hydroxyphenyl)iminoethylideneamino]phenol
InChI:
InChI=1S/C14H12N2O2/c17-13-7-3-1-5-11(13)15-9-10-16-12-6-2-4-8-14(12)18/h1-10,17-18H
InChI Key:
FZKAPSZEPRQQGK-UHFFFAOYSA-N
SMILES:
Oc1ccccc1/N=C/C=N/c1ccccc1O
EC Number:
214-560-0
UNII:
E2AW5XX09U
NSC Number:
68050
Properties
Complexity:
274  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
240.09g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
240.262g/mol
Monoisotopic Mass:
240.09g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
65.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  
Literature
Title Journal
A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation. Neurobiology of disease 20120301
High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation. Acta neuropathologica 20101001
Regulation of pH During Amelogenesis. Calcified tissue international 20100201
Chromium(III) determination without sample treatment by batch and flow injection potentiometry. Analytica chimica acta 20090216
Electronic structure of the glyoxalbis(2-hydroxyanil) (gha) ligand in [Co(III)(gha)(PPh3)2]+: radical vs. non-radical states. Dalton transactions (Cambridge, England : 2003) 20080714
Ancillary ligand determination of the spin location in both oxidised and reduced forms of diruthenium complexes bridged by bis-bidentate 1,4-bis(2-phenolato)-1,4-diazabutadiene. Dalton transactions (Cambridge, England : 2003) 20070521
Proteolysis on maturing enamel surface, as shown by gel-coating methods. European journal of oral sciences 20060501
A new coordination mode of the photometric reagent glyoxalbis(2-hydroxyanil) (H2gbha): bis-bidentate bridging by gbha2- in the redox series [(mu-gbha)[Ru(acac)2]2]n (n = -2, -1, 0, +1, +2), including a radical-bridged diruthenium(III) and a Ru(III)/Ru(IV) intermediate. Inorganic chemistry 20051128
Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Annals of neurology 20040301
Chromium(III) ion selective electrode based on glyoxal bis(2-hydroxyanil). Talanta 20030704
Altered pH regulation during enamel development in the cystic fibrosis mouse incisor. Journal of dental research 20030501
Synthesis, crystal structure, spectral studies, and catechol oxidase activity of trigonal bipyramidal Cu(II) complexes derived from a tetradentate diamide bisbenzimidazole ligand. Inorganic chemistry 20010226
Properties